Professor Sir John Bell, who led a review into the £64 billion life sciences industry, will use a speech at the University of Birmingham's Institute of Translational Medicine on Wednesday to outline its findings.

He will say the strategy "capitalises on our strong science base to further build the industry into a globally-unique and internationally competitive life sciences ecosystem".

Business Secretary Greg Clark will announce a £146 million investment in cutting-edge healthcare, as he reiterates the Government's commitment to the sector at the launch.

The investment, to be spread over four years, will cover projects supporting advanced therapies, advanced medicines and vaccines development and manufacturing.

Describing life sciences as of "critical importance" to the UK's economy and health, Mr Clark is expected to say: "The Life Sciences Industrial Strategy demonstrates the world-class expertise the UK already has in this sector and represents the industry's vision for how we can build on our world-leading reputation in this field."

Health Secretary Jeremy Hunt will announce £14 million of funding support for 11 medical technology research centres to bring new technologies to patients by encouraging collaboration between industry and the NHS.

He will say: "I want patients to continue to be at the front of the queue for the best treatments available, whether that means early access to trials, giving staff brand new innovations and technology to work with, or being at the heart of research to share best practice quickly across the health and social care system.

"A strong and growing life sciences sector ensures this, particularly as we negotiate our exit from the EU."

Sir John is expected to say: "The vision for the Life Sciences Industrial Strategy is an ambitious one and sets out proposals for how the UK can continue to capitalise on its strengths in the sector, both to encourage economic growth and to improve health outcomes for patients. "We have created a strategy which capitalises on our strong science base to further build the industry into a globally-unique and internationally competitive life sciences eco-system, supported by collaboration across industry, Government, the NHS, academia, and research funders to deliver health and wealth. "I look forward to working with Government to consider the strategy's recommendations, including those that can be taken forward as part of an ambitious Sector Deal."